Answer
Yes, particularly in Parkinson’s disease and when used with other dopaminergic treatment. Report hallucinations or increasing confusion to the treating team.
Sources for this answer
- NHSNHS · NHS medicine guidance
- Pipexus prolonged-release tabletsemc · SmPC Current selected SmPC · Version 8